Cargando…
Cardiogenic Shock in COVID 19 Fulminant Myocarditis Treated with V-A ECMO
INTRODUCTION: As COVID-19 pandemic spread, cases of involvement of the heart have been reported. CASE REPORT: A 47-year-old woman was admitted to the ICU of our hospital for severe cardiogenic shock. She was pyretic, hypoxemic, tachycardic and with reduction of voltages at ECG. TTE showed severe biv...
Autores principales: | D'Errico Ramirez, A., Giovannico, L., Parigino, D., Capone, G., Lionetti, G., Santeramo, V., Fischetti, G., Ursi, R., Civita, A., Grasso, S., Milano, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988710/ http://dx.doi.org/10.1016/j.healun.2022.01.679 |
Ejemplares similares
-
Immune-Checkpoint Inhibitor-Induced Fulminant Myocarditis and Cardiogenic Shock
por: Itzhaki Ben Zadok, Osnat, et al.
Publicado: (2019) -
Elasomeran: Acute fulminant lymphocytic myocarditis and cardiogenic shock: case report
Publicado: (2022) -
An Undetected Pheochromocytoma Leading to Fulminant Adrenergic Myocarditis Complicated by Cardiogenic Shock
por: Tran, Nam Q, et al.
Publicado: (2023) -
Fulminant Giant Cell Myocarditis and Cardiogenic Shock: An Unusual Presentation of Malignant Thymoma
por: Koul, Deepak, et al.
Publicado: (2010) -
Fulminant myocarditis and cardiogenic shock during SARS-CoV-2 infection()
por: Lozano Gómez, Herminia, et al.
Publicado: (2020)